Verve Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Verve Therapeutics, Inc. has filed 344 SEC EDGAR filings since 22 Jan 2021

SEC filing history

Showing 201-225 of 344 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
11 Aug 2022
Reporting date
10 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92605

SC 13G/A filing

Filing date
10 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Jul 2022
Reporting date
26 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jul 2022
Reporting date
20 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Jul 2022
Reporting date
19 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-265996

424B5

Filing date
21 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-265996

424B5

Filing date
20 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2022
Reporting date
07 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2022
Reporting date
13 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jul 2022
Reporting date
12 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265996

EFFECT filing

Filing date
12 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-265996

S-3

Filing date
01 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2022
Reporting date
29 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .